Atomo Diagnostics (ASX:AT1) Debt-to-Asset : 0.02 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Atomo Diagnostics Debt-to-Asset?

Atomo Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.17 Mil. Atomo Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.03 Mil. Atomo Diagnostics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was A$9.25 Mil. Atomo Diagnostics's debt to asset for the quarter that ended in Dec. 2024 was 0.02.

Atomo Diagnostics Debt-to-Asset Historical Data

The historical data trend for Atomo Diagnostics's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atomo Diagnostics Debt-to-Asset Chart

Atomo Diagnostics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

Debt-to-Asset

0.01

0.02

0.01

Atomo Diagnostics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial						0.01	0.02	0.01	0.01	0.02

Competitive Comparison of Atomo Diagnostics's Debt-to-Asset

For the Medical Devices subindustry, Atomo Diagnostics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atomo Diagnostics's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Atomo Diagnostics's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Atomo Diagnostics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Atomo Diagnostics's Debt-to-Asset for the fiscal year that ended in Jun. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.085	+	0.057)	/	10.943
	=	0.01

Atomo Diagnostics's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.174	+	0.025)	/	9.249
	=	0.02

Atomo Diagnostics (ASX:AT1) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Atomo Diagnostics Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Atomo Diagnostics's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Atomo Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atomo Diagnostics Ltd (ASX:AT1) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 - 5 George Street, Level 1, Leichhardt, Syndey, NSW, AUS, 2040

Website

https://www.atomodiagnostics.com

Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.

Atomo Diagnostics Headlines

No Headlines